XML 71 R40.htm IDEA: XBRL DOCUMENT
v3.23.1

Share-based Compensation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Share-based Compensation |
Summary of share-based compensation | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the year ended December 31,
​ | ​ | 2020 | ​ | 2021 | ​ | 2022 | ​ | 2022
​ |  | RMB |  | RMB |  | RMB |  | US$
Cost of revenues |  | 14,789 |  | 11,484 |  | 7,052 |  | 1,022
Selling and marketing expenses |  | 2,370 |  | 3,431 |  | 2,259 |  | 328
General and administrative expenses |  | 16,128 |  | 12,496 |  | 9,659 |  | 1,400
Research and development expenses |  | 17,454 |  | 9,948 |  | 10,263 |  | 1,488
Total |  | 50,741 |  | 37,359 |  | 29,233 |  | 4,238
​
summary of the company's stock options activities | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | ​ |  | ​ |  | ​ |  | ​ |  | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Weighted average | ​ | Remaining | ​ | Aggregated
​ | ​ | Employees | ​ | Consultants | ​ | Total | ​ | exercise price | ​ | contractual life | ​ | intrinsic value
​ | ​ | (in thousands) | ​ | (in thousands) | ​ | (in thousands) | ​ | US$ | ​ | ​ | ​ | RMB
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Outstanding at January 1, 2020 |  | 11,821 |  | 500 |  | 12,321 |  | 0.0001 |  | 2.75 |  | 43,011
Granted |  | 32,932 |  | 363 |  | 33,295 |  | 0.0001 |  | — |  | —
Exercised |  | (3,235) |  | — |  | (3,235) |  | 0.0001 |  | — |  | —
Forfeited |  | (3,714) |  | — |  | (3,714) |  | 0.0001 |  | — |  | —
Outstanding at December 31, 2020 |  | 37,804 |  | 863 |  | 38,667 |  | 0.0001 |  | 3.09 |  | 48,921
Exercisable as of December 31, 2020 |  | 5,002 |  | 250 |  | 5,252 |  | 0.0001 |  | — |  | 6,644
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Outstanding at January 1, 2021 |  | 37,804 |  | 863 |  | 38,667 |  | 0.0001 |  | 3.09 |  | 48,921
Granted |  | 32,389 |  | — |  | 32,389 |  | 0.0001 |  | — |  | —
Exercised |  | (4,925) |  | — |  | (4,925) |  | 0.0001 |  | — |  | —
Forfeited |  | (15,571) |  | — |  | (15,571) |  | 0.0001 |  | — |  | —
Outstanding at December 31, 2021 |  | 49,697 |  | 863 |  | 50,560 |  | 0.0001 |  | 2.56 |  | 29,786
Exercisable as of December 31, 2021 |  | 8,216 |  | 341 |  | 8,557 |  | 0.0001 |  | — |  | 5,041
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Outstanding at January 1, 2022 | ​ | 49,697 | ​ | 863 | ​ | 50,560 | ​ | 0.0001 | ​ | 2.56 | ​ | 29,786
Granted | ​ | 24,924 | ​ | — | ​ | 24,924 | ​ | 0.0001 | ​ | — | ​ | —
Exercised | ​ | (7,894) | ​ | — | ​ | (7,894) | ​ | 0.0001 | ​ | — | ​ | —
Forfeited | ​ | (6,076) | ​ | — | ​ | (6,076) | ​ | 0.0001 | ​ | — | ​ | —
Outstanding at December 31, 2022 | ​ | 60,651 | ​ | 863 | ​ | 61,514 | ​ | 0.0001 | ​ | 2.98 | ​ | 13,452
Exercisable as of December 31, 2022 | ​ | 16,421 | ​ | 682 | ​ | 17,103 | ​ | 0.0001 | ​ | — | ​ | 3,740
​
Summary of restricted shares activities | ​
​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Weighted-Average
​ | ​ | Number of Restricted Shares | ​ | Grant Date
​ | ​ | Granted | ​ | Fair Value
​ |  | (in thousands) |  | US$
​ | ​ | ​ | ​ | ​
January 1, 2020 |  | 24,928 |  | 0.23
Awarded |  | 2,607 |  | 0.27
Forfeited |  | (7,821) |  | 0.26
Vested |  | (9,857) |  | 0.22
Outstanding at December 31, 2020 |  | 9,857 |  | 0.23
​ | ​ | ​ | ​ | ​
January 1, 2021 |  | 9,857 |  | 0.23
Awarded |  | — |  | —
Forfeited |  | — |  | —
Vested |  | (6,232) |  | 0.24
Outstanding at December 31, 2021 |  | 3,625 |  | 0.21
​ | ​ | ​ | ​ | ​
January 1, 2022 | ​ | 3,625 | ​ | 0.21
Awarded |  | — |  | —
Forfeited |  | — |  | —
Vested | ​ | (3,625) | ​ | 0.21
Outstanding at December 31, 2022 | ​ | — | ​ | —
​ ​
​ | ​ | ​ | ​ | ​
​ |  | Number of Restricted Share |  | Weighted-Average
​ | ​ | Units Granted | ​ | Grant Date Fair Value
​ | ​ | (in thousands) | ​ | US$
​ | ​ | ​ | ​ | ​
January 1, 2020 |  | — |  | —
Awarded |  | 9,611 |  | 0.22
Forfeited |  | (5,101) |  | 0.24
Vested |  | — |  | —
Outstanding at December 31, 2020 |  | 4,510 |  | 0.20
​ | ​ | ​ | ​ | ​
January 1, 2021 |  | 4,510 |  | 0.20
Awarded |  | 13,080 |  | 0.30
Forfeited |  | (2,308) |  | 0.20
Vested |  | (3,018) |  | 0.19
Outstanding at December 31, 2021 |  | 12,264 |  | 0.31
​ | ​ | ​ | ​ | ​
January 1, 2022 | ​ | 12,264 | ​ | 0.31
Awarded | ​ | 2,193 | ​ | 0.07
Forfeited | ​ | (2,612) | ​ | 0.33
Vested | ​ | (3,649) | ​ | 0.29
Outstanding at December 31, 2022 | ​ | 8,196 | ​ | 0.29

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration